232 related articles for article (PubMed ID: 31846892)
21. Co-Delivery of Docetaxel and Berbamine by Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Enhancing Bioavailability and Anticancer Activities.
Wu J; Bu X; Dou L; Fang L; Shen Q
J Biomed Nanotechnol; 2015 Oct; 11(10):1847-57. PubMed ID: 26502647
[TBL] [Abstract][Full Text] [Related]
22. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
[TBL] [Abstract][Full Text] [Related]
23. Development of self-assembled nanocarriers to enhance antitumor efficacy of docetaxel trihydrate in MDA-MB-231 cell line.
Rarokar NR; Khedekar PB; Bharne AP; Umekar MJ
Int J Biol Macromol; 2019 Mar; 125():1056-1068. PubMed ID: 30572051
[TBL] [Abstract][Full Text] [Related]
24. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H
Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807
[TBL] [Abstract][Full Text] [Related]
25. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
[TBL] [Abstract][Full Text] [Related]
26. Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach.
Kurmi BD; Paliwal R; Paliwal SR
Int J Biol Macromol; 2020 Dec; 164():2881-2894. PubMed ID: 32853621
[TBL] [Abstract][Full Text] [Related]
27. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
[TBL] [Abstract][Full Text] [Related]
28. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
[TBL] [Abstract][Full Text] [Related]
29. Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study.
Varshosaz J; Taymouri S; Jahanian-Najafabadi A; Alizadeh A
IET Nanobiotechnol; 2018 Sep; 12(6):795-806. PubMed ID: 30104454
[TBL] [Abstract][Full Text] [Related]
30. Docetaxel and alpha-lipoic acid co-loaded nanoparticles for cancer therapy.
Kothari IR; Mazumdar S; Sharma S; Italiya K; Mittal A; Chitkara D
Ther Deliv; 2019 Apr; 10(4):227-240. PubMed ID: 30991918
[No Abstract] [Full Text] [Related]
31. Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy.
Kumar Mehata A; Bharti S; Singh P; Viswanadh MK; Kumari L; Agrawal P; Singh S; Koch B; Muthu MS
Colloids Surf B Biointerfaces; 2019 Jan; 173():366-377. PubMed ID: 30316083
[TBL] [Abstract][Full Text] [Related]
32. Implementation of two different experimental designs for screening and optimization of process parameters for metformin-loaded carboxymethyl chitosan formulation.
De A; Kuppuswamy G; Jaiswal A
Drug Dev Ind Pharm; 2019 Nov; 45(11):1821-1834. PubMed ID: 31486683
[TBL] [Abstract][Full Text] [Related]
33. PEG-conjugated triacontanol micelles as docetaxel delivery systems for enhanced anti-cancer efficacy.
Lu X; Fang M; Yang Y; Dai Y; Xu J; Zhao D; Lu Y; Chen X; Lu S; Li N
Drug Deliv Transl Res; 2020 Feb; 10(1):122-135. PubMed ID: 31444736
[TBL] [Abstract][Full Text] [Related]
34. LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer.
Shitole AA; Sharma N; Giram P; Khandwekar A; Baruah M; Garnaik B; Koratkar S
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111035. PubMed ID: 32994029
[TBL] [Abstract][Full Text] [Related]
35. Translocation and toxicity of docetaxel multi-walled carbon nanotube conjugates in mammalian breast cancer cells.
Arora S; Kumar R; Kaur H; Rayat CS; Kaur I; Arora SK; Srivastava J; Bharadwaj LM
J Biomed Nanotechnol; 2014 Dec; 10(12):3601-9. PubMed ID: 26000373
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
37. Cabazitaxel and thymoquinone co-loaded lipospheres as a synergistic combination for breast cancer.
Kommineni N; Saka R; Bulbake U; Khan W
Chem Phys Lipids; 2019 Nov; 224():104707. PubMed ID: 30521787
[TBL] [Abstract][Full Text] [Related]
38. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
[TBL] [Abstract][Full Text] [Related]
40. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
